Alyeska Investment Group
ACAD icon

Alyeska Investment Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Alyeska Investment Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,696
Closed -$1.58M – 559
2024
Q1 		$1.58M Sell
85,696
-499,340
-85% -$12.4M 0.01% 391
2023
Q4 		$18.3M Buy
585,036
+185,036
+46% +$4.42M 0.12% 213
2023
Q3 		$8.34M Buy
+400,000
New +$10.9M 0.06% 305
2019
Q1 		– Sell
-175,000
Closed -$2.83M – 368
2018
Q4 		$2.83M Buy
+175,000
New +$3.4M 0.04% 267
2018
Q2 		– Sell
-614,166
Closed -$13.8M – 447
2018
Q1 		$13.8M Sell
614,166
-41,336
-6% -$1.14M 0.12% 196
2017
Q4 		$19.7M Buy
655,502
+289,583
+79% +$9.26M 0.16% 157
2017
Q3 		$13.8M Sell
365,919
-80,511
-18% -$2.62M 0.11% 215
2017
Q2 		$12.5M Buy
446,430
+73,593
+20% +$2.19M 0.11% 221
2017
Q1 		$12.8M Buy
+372,837
New +$13.2M 0.11% 236

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return